Clinical Research

LVPEI has been successfully audited by United States - Food and Drug Administration Agency (US FDA) and European Medicine Agency (EMA) for performing clinical trials.

Raja Narayanan, Director, Clinical Research
Contact: 040-3061 2618
Mail: narayanan@lvpei.org


Kallam Anji Reddy Campus
Manager Operations: T. Charitha
Study Co-ordinators: Deepthi, Ravi Teja, Kranthi Kumar, Esankara Raju, Aseema, Soundharya
Study Optometrists: Mr. Abhilash Goud, M. Liviza
Senior Clinical Data Analyst : E. Shobha Laxmi
Data Entry Operator: V. Vijaya Laxmi.

Contact Numbers (Clinical Research) : 040-3061 2123/2124

Contact Number (Bio statistician and Image Reading center) : 040-3061 2170


Bhubaneswar Campus
Clinical Research Coordinators: Debashish Das, Mohammed Hasibur Rahman
Study Optometrists: Mr.Krushna Gopal Panda, Mr. Aniruddha Banerjee.


Optometrists Involved In Research
Optometrists Involved In Research

KAR Campus
S.No Name of the Project Principal Investigator Collaborator Duration
1. A Phase III, Multi-National, Multi-Center, Randomized, Masked, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal (FAI) Insert in Subjects with Chronic Non-Infectious Uveitis Affecting the Posterior Segment of the Eye. Dr Mudit Tyagi Excel Life Sciences 2012–2018
2. An observational muti-center, open, study assessing the efficacy and safety of Ranibizumab intravitreal injections (IVI) of in patients with visual impairment due to Macular edema secondary to retinal vein occlusion(RVO) Dr Raja Narayanan Novartis 2016-2017
3. A multi center,open label, observational study to evaluate the efficacy and safety of intravitreal injections (IVI)of Ranibizumab in patients with visual impairment due to Diabetic Macular Edema (DME) Dr Padmaja Kumari Novartis 2012-2016
4. Retinopathy of Prematurity (ROP) Dr Subhadra Jalali Public Health foundation 2016-2017
5. A Phase 2/3, Randomized , Double Masked, Sham Controlled trial of QPI-1007 delivered by single or multi dose intravitreal injection(s) to subjects with acute non arteritic anterior Ischemic optic neuropathy (NAION) Dr Ramesha Kekunnaya Quark Pharmaceuticals, Inc. 2016-2017
6. A Prospective, Multicenter clinical study to assess safety,Immunogenicity and Efficacy of Ranibizumab (Intas Pharmaceutical Limited) for the treatment of treatment of Wet AMD(Age Related macular Degeneration) Dr Vivek Dave Intas Pharmaceutical Limited 2017-2018
7. An Observational, prospective,post marketing surveillance program to evaluate the safety profile of Intravitreal Ozurdex® in the treatment of visual impairment due to diabetic macular edema by actively identifying and evaluating the occurrence of adverse events and serious adverse events information. Dr Divya Balakrishnan Clintec International 2017-2018
8. A Phase 3, RandomizEd, MAsked, Controlled Clinical Trial to Study the Safety and Efficacy of Triamcinolone Acetonide Injectable Suspension (CLS-TA) for tHe TReatment of Subjects with Macular Edema associated with Non-Infectious UvEitis. Dr Mudit Tyagi Excel Life Sciences 2017-2018
9. A Phase III, Randomized, Observer-Masked, Active-Controlled, Parallel-Group, Multinational and Multicenter Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution 0.002% Compared with Latanoprost Ophthalmic Solution 0.005% in Subjects with Open-Angle Glaucoma or Ocular Hypertension-PEONY Study Dr Sirisha Senthil Santen Pharmaceutical Co., Ltd. 2017-2018

GMRV Campus
S.No Name of the Project Principal Investigator Supported by Duration
1. Comparative study between axial length measurement by Immersion and Contact A scan of eyes with poor fixation Dr Varada In-House 2017-2018
2. Comparison of under correction of intra ocular lens power calculation in children and its effect on various intraocular lens power calculation formulae Dr Virender Sachdeva In-House 2017-2018

MTC Campus, Bhubaneswar, Odisha
S.No Name of the Project Principal Investigator Supported by Duration
1. A Phase III, Multi-National, Multi-Center, Randomized, Masked, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal (FAI) Insert in Subjects with Chronic Non-Infectious Uveitis Affecting the Posterior Segment of the Eye. Dr Soumyava Basu Psidiva Corp 2014-2018
2. A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects with Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program (Spring Study) Extension of SAKURA Dr Soumyava Basu Santen Incorporated 2015-2018
3. A Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial Of QPI-1007 Delivered By Single or Multi-Dose Intravitreal Injections To Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) Dr Vivekanand Uttamrao Warkad Quark Pharmaceutical 2016-2019
4. A Prospective, Multicenter Clinical Study to Assess Safety,Immunogenicity and Efficacy of Ranibizumab (Intas Pharmaceuticals Limited) for the Treatment of Wet AMD (Age Related Macular Degeneration) Dr Soumyava Basu Intas Pharmaceutical Ltd 2016-2018
TOP